Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishna Vaddi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|December 10, 2003
Transgenic animals in inflammatory disease modelsCarrie M Brodmerkel, Krishna Vaddi
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|September 21, 2023
A Quality Improvement Initiative to Increase the Milk Donation to the Human Milk Bank Post-Coronavirus Disease-19 PandemicVamsi Krishna Vaddi, Dwayne Mascarenhas, S B Kirthana, et al.
Indian Journal of Pediatrics|February 15, 2018
Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile SpasmsVamsi Krishna Vaddi, Jitendra Kumar Sahu, Sumeet R Dhawan, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|December 10, 2003
Transgenic animals in inflammatory disease modelsCarrie M Brodmerkel, Krishna Vaddi
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|September 21, 2023
A Quality Improvement Initiative to Increase the Milk Donation to the Human Milk Bank Post-Coronavirus Disease-19 PandemicVamsi Krishna Vaddi, Dwayne Mascarenhas, S B Kirthana, et al.
Indian Journal of Pediatrics|February 15, 2018
Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile SpasmsVamsi Krishna Vaddi, Jitendra Kumar Sahu, Sumeet R Dhawan, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Pageof 2